IGF1 and breast carcinoma: Chronic stimulation by GH/insulin-like growth factor-1 (IGF-1) has been described as a potential pathophysiologic explanation [5], with clinical evidence available outside of the acromegaly setting, for breast cancer [6], colorectal cancer [7] and prostate cancer [8].